The results of this study showed that IFN‐γ and VEGF‐A expression levels were significantly higher than normal in psoriasis patients before treatment and decreased significantly after secukinumab treatment, but the levels remained significantly higher than normal after treatment. The gene discussed is VEGFA; the disease is psoriasis.